SCHEMBL19820344

SCHEMBL19820344

CC(C)C(C)c1nc(C(C)(C)C)c2[nH]ccc2n1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24996409 0.87 TYK2 (0.34)
SCHEMBL10139171 0.75 DYRK1A (0.32)
SCHEMBL12396387 0.71 ADORA2A (0.34)
SCHEMBL2739652 0.66 DYRK1A (0.53) JAK2
SCHEMBL14104385 0.65 MAPK1 (0.41)
SCHEMBL25549142 0.65 TYK2 (0.36)
SCHEMBL18711832 0.64 TYK2 (0.41)
SCHEMBL19820315 0.61 HRH4 (0.34) JAK2
SCHEMBL24996725 0.61 AAK1 (0.36)
SCHEMBL22693058 0.61 KDM4E (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9879028-B2 Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith Gatekeeper Pharmaceuticals, Inc. (US) 2018-01-30 US disclosed